Health ❯ Medicine

Endocrinology

Diabetes Hormones Hormone Therapy Obesity Insulin Resistance Hormonal Treatments Puberty Blockers Glucose Metabolism GLP-1 Receptor Agonists Diabetes Management Metabolic Disorders Hypoparathyroidism Sex-specific hormones Hormone Treatments Diabetic Complications Hormonal Influence Hormonal Disorders Insulin Release Osteoporosis GLP-1 Agonists GLP-Based Therapies Hormonal Imbalance Metabolism

Pentagon Orders Testosterone Screening for Service Members Over 30

The policy has drawn medical skepticism and fast-moving court scrutiny because the department has not published clinical rules or monitoring plans.

Tirzepatide Raises Imaging Signals of Brown Adipose Tissue in Small Randomized Trial

Early Evidence Suggests GLP‑1 Weight Drugs Can Raise Testosterone and Improve Sperm in Men With Obesity

Five-Target ‘Trojan Horse’ Drug Outperforms Leading Incretins in Obese Diabetic Mice

High-Resolution Map of Pancreatic Cell DNA Methylation Ties ONECUT2 to Type 2 Diabetes

Common Gene Variants May Blunt GLP-1 Diabetes Drugs for 1 in 10 People

Mouse Study Finds Semaglutide Directly Reprograms Liver Cells to Ease Disease Without Weight Loss

Androgen Signaling Drives Lethal Pediatric Ependymoma, Study Finds

Brain Maps of GLP-1 Drugs Point to Paths for Weight Loss Without Nausea

Real-World Study Finds Semaglutide and Tirzepatide Cut Cardiovascular Risk in Type 2 Diabetes

Small Molecule Blocks RAGE–DIAPH1 Pathway, Reduces Diabetic Tissue Damage in Mice

Metformin Requires Hypothalamic Rap1 Inactivation to Lower Blood Sugar

GLP-1 Weight-Loss Drugs Linked to Testosterone Normalization in Men